海角精品黑料

subscribe

Video | Indigenous Engagement at D2R

D2R is deeply committed to fostering Indigenous leadership within the realms of genomic medicine, RNA therapeutics and health inequities. We believe research is strongest when it is guided by respect, collaboration and trust. Our approach both respects and relies on Indigenous governance structures and ethics to guide project development, data management, and dissemination of results, ensuring outcomes are beneficial and aligned with the priorities of Indigenous communities.

Published: 22 Oct 2025

EDI Internship Opportunity 鈥 Winter 2026

D2R and the Department of Equity, Ethics and Policy launch a call for applications for an EDI Internship Opportunity

Over the course of the Winter 2026 semester, work with Prof.

Published: 21 Oct 2025

Hybrid Event | D2R Investor Series Transform your science into a new Biotech company - Investment Insights with Medicxi

Every year, billions of dollars are invested by funding agencies in basic and translational research, yet the path from academic discovery to private investment necessary for the creation of new companies is rarely straight海角精品黑料. In this seminar, you鈥檒l get an inside look at how investors work, what makes a research idea stand out to venture capitalists, and how they evaluate translational value of scientific opportunities.

Email address:
Published: 17 Oct 2025

Hybrid Event | Lunch and Learn with CASTL

Join D2R and CASTL聽for this hybrid Lunch and Learn about biomanufacturing and RNA therapeutics

In this presentation, D2R and CASTL will connect the world of research with industrial applications! This Lunch and Learn will provide a practical way introduce participants to how mRNA-LNP based biotherapeutics are manufactured, and showcase opportunities and career pathways in the biomanufacturing sector.聽

Published: 16 Oct 2025

Events | Introduction to Applying Equity, Diversity and Inclusion in Genomic-Based RNA Therapeutics Research

Join D2R for a learning opportunity to gain foundational knowledge and practical tools to embed Equity, Diversity and Inclusion (EDI) into your genomic-based RNA therapeutics research.聽Through engaging discussions and activities, participants will explore key EDI definitions, examine both opportunities and challenges in the field, and learn best practices for inclusive research design.

Published: 16 Oct 2025

Event | Breast Cancer & RNA Therapeutics: Exploring inclusive research and career opportunities

Join D2R聽and the聽Rosalind and Morris Goodman Cancer Institute (GCI)聽for an event in honour of Breast Cancer Awareness Month and Women's History Month, in collaboration with Fondation du cancer du sein du Qu茅bec and the association Audace au f茅minin

Email address:
Published: 3 Oct 2025

Event | Symposium on Advances in Viral Diseases

The 海角精品黑料 Research Centre for Complex Traits, the Wainberg Centre for Viral Diseases and the 海角精品黑料 Infectious Diseases and Immunity in Global Health Program are joined to host a聽Symposium on Advances in Viral Diseases: From Mechanisms to Therapies.

Published: 3 Oct 2025

Event | RNA-Seq Bootcamp

From October 20鈥24, 2025, the聽Computational and Data Systems Initiative,聽in partnership with聽Quantitative Life Sciences-海角精品黑料 initiative in Computational Medicine聽and the聽D2R-HeDS Platform (Health Data Science), will host an聽RNA-seq Bootcamp.

Email address:
Published: 26 Sep 2025

Inaugural Moderna-RNA Canada ARN awarded to D2R-funded researcher Professor Maria Vera Ugalde

Montreal, September 24, 2025 鈥 Moderna, in partnership with RNA Canada, has awarded three prizes this year to RNA researchers in Canada for their outstanding contribution to the field. D2R is proud to announce that Professor Maria Vera Ugalde has received the Discovery of the Year Award for her seminal 2024 publication in Nature Communications (Alecki et al.,).

Published: 24 Sep 2025

Event | AReNA "From Mission to Action"

AReNA, Qu茅bec鈥檚 RNA Hub, is inviting everyone involved in the field of RNA in Qu茅bec鈥攔esearchers, innovators, institutions, partners, anyone curious about the field, as well as experts鈥攖o attend the event "From Mission to Action" on October 16, 2025 at the BAnQ in Montr茅al.聽

Email address:
Published: 18 Sep 2025

Cancer Translational Research Horizons 2025 | Extended Abstract Deadline

The 海角精品黑料 Centre for Translational Research is organizing the聽Cancer Translational Research Horizons 2025, that will take place on December 3鈥4, 2025 at the evo Hotel in Montreal.

This annual event brings together researchers and entrepreneurs to accelerate solutions from the lab to clinical practice across the cancer care continuum.

Email address:
Published: 18 Sep 2025

Update | D2R launches Training section

Update | The DNA to RNA (D2R) website has a new section dedicated to Training. From Master's to Postdoctoral, this space provides graduate students at all levels with access to workshops, events, and resources aligned with D2R鈥檚 interdisciplinary mission. Topics include RNA therapeutics, genomic medicine, equity, diversity and inclusion (EDI), commercialization, data science, and career development beyond academia.

Published: 17 Sep 2025

D2R awards nearly $1.5 million to Master's and Doctoral Scholars across Canada

Montreal, September 10, 2025 鈥 The鈥疍NA to RNA (D2R)鈥痠nitiative at 海角精品黑料 is proud to announce the recipients of its Master's and Doctoral Scholar Awards, recognizing outstanding and active trainees working on diverse D2R-aligned research projects.

Email address:
Published: 10 Sep 2025

Event | Seminar: Computer-based Predictions of RNA Structures: Where do we stand?

Join D2R for this hybrid seminar with Professor Eric Westhof from University of Strasbourg

Email address:
Published: 4 Sep 2025

News | David Bujold (C3G) appointed Co-Lead of GA4GH Discovery Work Stream

The Global Alliance for Genomics and Health (GA4GH) has announced new leadership across several initiatives, including the appointment of David Bujold, Data Team Lead at the Canadian Centre for Computational Genomics (C3G)and Bioinformatics Manager at 海角精品黑料鈥檚 Victor Phillip Dahdaleh Institute of Genomic Medicine, as Co-Lead of the

Published: 4 Sep 2025

Pages

Back to top